Connect with us
https://tickernews.co/wp-content/uploads/2023/10/AmEx-Thought-Leaders.jpg

Money

Theranos founder faces court on fraud charges

Published

on

The trial into the now-defunct blood testing startup Theranos has begun, with founder Elizabeth Holmes facing several charges of criminal fraud.

Prosecutors alleged Holmes “lied and cheated” for money and fame during the first day of one of the most closely watched trials of a U.S corporate executive in years.

The former Silicon Valley star is accused of deceiving investors and patients, by claiming Theranos technology could detect common illnesses using just a few drops of blood from a finger prick.

The company collapsed in 2015 after it emerged the blood-testing devices did not work, and had instead been operating commercially available machines made by other manufacturers.

“Significant problems brewing”

Prosecutors claimed that Holmes and other executives turned to fraud in 2009 after big pharmaceutical firms refused to back Theranos and the company faced bankruptcy.

Holmes lied about tests and exaggerated the company’s performance to secure millions of dollars of investments between 2010 to 2015.

This included false claims that the tests had been processed by pharmaceutical giant Pfizer, and that the technology was being used in the field by the U.S military.

Defence tells court Holmes is “no villain”

At the centre of Holmes’ defence is the argument she never intended to commit fraud.

Instead, they argue, Theranos is a high-profile example of a startup that simply did not work, much like thousands of other failed business ideas.

They told jurors that Holmes is not a villain, but rather a hard-working, young and naive businesswoman, who poured much of her life into the company.

“Failure is not a crime. Trying your hardest and coming up short is not a crime,” defence attorney Lance Wade said.

“In the end, Theranos failed and Ms Holmes walked away with nothing,” he told the jury.

Former executive and romantic partner also charged

Ex-Theranos executive Ramesh Balwani – who was romantically involved with Holmes for years, faces the same charges, but will be tried separately.

He has pleaded not guilty.

According to court documents released to the public, Holmes has accused Balwani of years of emotional and psychological abuse – allegations which Balwani denies.

Holmes’ lawyers have indicated she is highly likely to take the witness stand and testify about the effect her relationship with Balwani had on her mental state.

Court case the culmination of ill-fated saga

Holmes’ story is one which has peaked public interest.

After founding Theranos in 2003, aged 19, Holmes was fast-tracked for Silicon Valley success – she was at one point dubbed the world’s youngest self-made female billionaire and the “next Steve Jobs”.

Theranos “dazzled” large firms such as Walgreens and pharmacy companies into agreeing testing partnerships, as well as securing investments from high-profile figures like media mogul Rupert Murdoch and former U.S secretary of state Henry Kissinger.

Her story has become the subject of documentaries, podcasts and books. A TV miniseries and a film based on her life are in the works.

A tumultuous story will now culminate in a decision made in a California courtroom, with the case expected to last months.

If guilty, Holmes faces up to 20 years in prison.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Money

Warner Brothers & Discovery considers splitting up to boost stock value

Published

on

Warner Bros Discovery is considering a strategic breakup to enhance its stock performance, according to a Financial Times report.

The potential move aims to unlock value by separating its media assets from its reality TV and lifestyle businesses.

This decision follows pressure from investors to improve stock performance, amidst challenges in the media industry #featured #trending

Continue Reading

Money

Investors worldwide grow increasingly optimistic about Trump winning the election

Published

on

Investors are increasingly optimistic about Donald Trump’s potential re-election, prompting a resurgence in the so-called ‘Trump trade’.

Market participants are closely monitoring Trump’s political strategies and public sentiment, influencing their investment decisions.

Kyle Rodda from Captial.com joins to discuss all the latest.

Continue Reading

Money

Netflix expands use of ads despite slow subscriber growth

Published

on

Netflix is intensifying its efforts to introduce an ad-supported tier amidst a plateau in subscriber growth.

The streaming giant hopes to attract new users and boost revenue by offering a cheaper alternative that includes advertisements.

This move marks a significant shift from its traditional ad-free model, reflecting Netflix’s response to competitive pressures and evolving consumer preferences.

Continue Reading

Trending Now